Skip to main content
. Author manuscript; available in PMC: 2014 May 14.
Published in final edited form as: J Natl Compr Canc Netw. 2011 Sep 1;9(9):1011–1018. doi: 10.6004/jnccn.2011.0085

Figure 1.

Figure 1

Progression-free survival according to University of California, Los Angeles Survival After Nephrectomy and Immunotherapy risk group.

Abbreviation: Int, intermediate.

Courtesy of David McDermott, MD, Boston, MA. Presented at the 2010 ASCO Annual Meeting; June 4–8, 2010; Chicago, Illinois.